Eagle Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-526,728
Closed -$24.3M 671
2016
Q3
$24.3M Sell
526,728
-391,141
-43% -$22.1M 0.16% 188
2016
Q2
$46.8M Sell
917,869
-99,891
-10% -$4.96M 0.32% 96
2016
Q1
$43M Sell
1,017,760
-38,959
-4% -$1.99M 0.3% 107
2015
Q4
$83M Sell
1,056,719
-4,203
-0.4% -$243K 0.55% 34
2015
Q3
$43M Sell
1,060,922
-317,100
-23% -$16.8M 0.29% 114
2015
Q2
$71.7M Buy
1,378,022
+19,717
+1% +$981K 0.4% 82
2015
Q1
$63.2M Buy
1,358,305
+5,642
+0.4% +$293K 0.36% 92
2014
Q4
$60.7M Sell
1,352,663
-1,560
-0.1% -$65.5K 0.35% 97
2014
Q3
$52.7M Sell
1,354,223
-1,880
-0.1% -$73.8K 0.3% 112
2014
Q2
$57.4M Buy
1,356,103
+51,701
+4% +$1.9M 0.31% 109
2014
Q1
$46.5M Buy
1,304,402
+661,709
+103% +$22.3M 0.26% 135
2013
Q4
$20.8M Buy
+642,693
New +$19.1M 0.12% 225

Other funds holding ISEE

Eagle Asset Management's ISEE Position: Q4 2016 in Review

Eagle Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 526,728 shares — an estimated $24.3M sold.

Eagle Asset Management first reported a position in ISEE in Q4 2013 and held it in 12 quarters. The position peaked at $83M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Eagle Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Eagle Asset Management sold 526,728 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $24.3M.
  • Eagle Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 12 quarters.
  • Eagle Asset Management's IVERIC bio, Inc. Common Stock position peaked at $83M in Q4 2015.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Eagle Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.